MDA SPACE LTD. (TSX: MDA.TO / NYSE: MDA)
EQUITY DEEP DIVE | AEROSPACE & DEFENSE | DUAL-LISTED
As of: June 9, 2026, 10:30 ET | Market: OPEN (TSX) | CLOSED (NYSE, pre-open)

IN FOCUS MDA Space is pulling back sharply from its May 28 ATH (CAD $67.90) after ATB Cormark’s May 29 downgrade, with TSX shares down ~8.8% intraday June 9 to CAD $40.82 — the question is whether a 40% selloff from ATH is an accumulation window or a valuation reality check for a stock still trading above 40x forward earnings.

1. LOG
Timestamp: June 9, 2026, ~10:30 ET | All fetches performed this session
Source # URLs Attempted Result Captured
[1] Price/Volume Yahoo Finance (CA), Robinhood, Yahoo Historical SUCCESS NYSE: ~$38.33 (Jun 5 close), -6.72%. TSX: CAD $40.82 intraday -8.80%. 52w range NYSE: $23.23-$49.37 | TSX: CAD $20.85-$67.90. Avg vol NYSE 897K; intraday 1.28M [FRESH]
[2] Fundamentals SEC 6-K filing (Q1 2026), StockTitan, PRNewswire, PitchBook SUCCESS Revenue, EBITDA, EPS, cash, debt from Q1 2026 earnings release. FY2025 from StockAnalysis [FRESH]
[3] Ownership/Short InsiderScreener, MarketBeat, Benzinga, Finimize PARTIAL Insider ownership ~12.6% (InsiderTrades.com). Short interest described as ‘low’ — exact % not scraped. Borrow fee [MISSING]
[4] Insider Transactions InsiderScreener, InsiderTrades.com, SimplyWallSt SUCCESS Net selling: ~CAD $11.9M in sales vs $100K buys in last 90 days. CEO Greenley sold C$5.8M in Jun 2025. Thornvale Holdings (director vehicle) sold $USD 12M+ Dec 25-Jan 26 [FRESH]
[5] Technicals ChartMill, TradingView, CNN, Yahoo PARTIAL RSI ~83 (overbought per ChartMill, ~4 weeks prior). TradingView: Strong Buy MA signal. ATH May 28 CAD $67.90. SMA levels [EST]
[6] Options Surface Yahoo Finance options (failed), no US options data scraped FAILED NYSE listing March 2026 — options data not confirmed available or liquid. IV rank, PCR [MISSING]
[7] News/Catalysts MDA IR newsroom, StockTitan, PRNewswire, Investing.com, CNN SUCCESS BAE Systems/SSC EPOCH2 win (Jun 2), CHORUS 41 early commitments (May 5), Airbus OneWeb antenna contract (Apr 20), DIA space surveillance contract (Mar 18). ATB downgrade May 29 [FRESH]
[8] Analyst Ratings Benzinga, ChartMill, TipRanks, MarketBeat, StockAnalysis SUCCESS Jefferies Buy $51 (Jun 2), RBC Buy $58 (May 11), JPMorgan OW $43 (May 14), Stifel Buy (Jun 4), ATB Cormark Sector Perform/Hold C$67 (May 29), CIBC Outperform C$57 [FRESH]
[9] Social Sentiment Web search for StockTwits/Reddit sentiment PARTIAL No direct StockTwits scrape completed. Stockchase analyst commentary sourced (99+ opinions, 4.15 rating). Retail sentiment generally positive on defense theme. Direct platform data [MISSING]
[10] Chart Reference Yahoo Finance (404), TradingView metadata, Robinhood PARTIAL ATH: CAD $67.90 (May 28). Current CAD $40.82 (-39.9% from ATH). NYSE 52w: $23.23-$49.37 [STALE]

2. CURRENT STATE
NOTE ON DUAL LISTING: All USD prices are NYSE (MDA). All CAD prices are TSX (MDA.TO). Financials reported in CAD. Today’s sharp move is on the TSX.

Field Value Tag
Price (NYSE, USD) [STALE]
Price (TSX, CAD) [STALE]
Volume (NYSE) [FRESH]
Volume (TSX Jun 9) [PARTIAL]
52-Week Range (NYSE) [FRESH]
52-Week Range (TSX) [FRESH]
Market Cap (NYSE basis) [FRESH]
Market Cap (TSX basis) [PARTIAL]
Float [EST]
SSR Active [MISSING]
After-Hours (NYSE) [STALE]

TAPE READ MDA hit an ATH of CAD $67.90 on May 28 and has since shed roughly 40% to the CAD $40 area in less than two weeks. ATB Cormark’s May 29 downgrade (to Sector Perform despite a C$67 target) lit the fuse, and the stock has not found a bid. NYSE volume on June 5 ran 43% above average, confirming distribution rather than orderly profit-taking. TSX June 9 volume is extremely thin at ~15% of normal — no panic capitulation yet, which could mean sellers are not done.

3. FUNDAMENTALS
Note: All financials in CAD per company reporting convention (IFRS). NYSE USD values are converted at ~0.73 CAD/USD.

Metric Value / Commentary Tag
Revenue (FY2025 actual) CAD $1.63B | YoY: +51.2% | Prior year: CAD $1.08B [FRESH]
Revenue (TTM per Yahoo) CAD ~$2.1B (note: may include PitchBook’s $1.17B TTM as of Apr-26 vs Yahoo’s $2.1B — discrepancy flagged) [PARTIAL]
Revenue Q1 2026 CAD $464.1M | YoY: +32.2% | Beat consensus ($413.8M) by 12.1% [FRESH]
FY2026 Revenue Guidance Not explicitly stated in scraped data. Adj. EBITDA guidance: CAD $320M-$370M (40% YoY growth midpoint). StockAnalysis shows FY2026 est: $1.83B (vs $1.63B, +12%) [EST]
Gross Margin Q1 2026 24.8% | Prior Q1 2025: not stated but improving [FRESH]
Adj. EBITDA Q1 2026 CAD $90.6M | Margin: 19.5% | YoY: +32.1% | Guidance range: 19-20% [FRESH]
GAAP Net Income Q1 2026 CAD $29.6M | YoY: -10.0% (amortization from SatixFy acquisition Q3 2025) [FRESH]
Adj. Net Income Q1 2026 CAD $50.7M | YoY: +32.0% [FRESH]
GAAP Diluted EPS Q1 2026 CAD $0.22 | YoY: -11.5% (dilution from NYSE IPO share issuance) [FRESH]
Adj. Diluted EPS Q1 2026 CAD $0.38 | YoY: +26.9% | Beat consensus $0.32 by 18.9% [FRESH]
Cash (Q1 2026 end) CAD $544.0M (vs CAD $152.0M at YE2025 — boosted by NYSE IPO proceeds of $441.5M net) [FRESH]
Long-Term Debt (Q1 2026) CAD $244.7M [FRESH]
Net Cash Position CAD +$299.3M | Net debt/Adj. TTM EBITDA: (0.9)x — net cash [FRESH]
Free Cash Flow Q1 2026 CAD $(27.6)M | Down from +$205.3M in Q1 2025 (working capital + higher CapEx) [FRESH]
Backlog (Q1 2026 end) CAD $3,692.7M | Down from $4,838.4M a year prior (converting rapidly) [FRESH]
Order Bookings Q1 2026 CAD $143.9M vs $803.9M in Q1 2025 — sharp drop, flagged as risk [FRESH]
CAD 40B Pipeline (5-year) ~CAD $30B tied to satellite systems; balance in geo-intel, defense, robotics [FRESH]
P/E (Trailing, NYSE) ~67-84x depending on source (GAAP EPS ~$0.57 USD TTM) [STALE]
Forward P/E (NYSE) ~39.5-44x [STALE]
P/S (TTM) ~4.3x (NYSE) | EV/Revenue: ~4.4x | EV/EBITDA: ~23.6x [STALE]
Credit Rating BB- (S&P) — non-investment grade / speculative [MEM]

Dilution Watch
NYSE IPO (completed March 2026): 11,180,136 new shares issued at US$30.50, generating net proceeds of CAD $441.5M. This is done — dilution already in the share count. No active ATM, ELOC, or convertible notes found in scrape. Base shelf prospectus filed March 2026 on SEDAR+ for general funding flexibility. [FRESH]

FUNDAMENTALS READ The operating story is clean: 30%+ revenue growth, Q1 beat, net cash balance sheet, and a CAD $40B pipeline. The problems are two: (1) order bookings collapsed in Q1 — CAD $143.9M vs $803.9M a year prior, meaning backlog is burning down without refill; and (2) GAAP EPS declined YoY because the SatixFy acquisition is front-loading amortization. Valuation at 39-44x forward earnings is pricing perfection in a spec-grade company. BB- credit rating means any stumble gets punished harder than investment-grade peers.

4. POSITIONING & OWNERSHIP
Field Value Tag
Short Interest Described as ‘low’ in multiple sources — exact % not scraped [MISSING]
Borrow Fee Not scraped [MISSING]
Institutional Ownership Higher on TSX shares per Finimize; Connor, Clark & Lunn recently acquired significant stake (Gurufocus Jun 2026). Exact % not scraped. [PARTIAL]
Insider Ownership ~12.6% (InsiderTrades.com data) [PARTIAL]
Insider Activity (last 90d) Net SELLING: ~CAD $11.9M in sales vs CAD $100K buys. Director John Carter Risley: sold ~CAD $10.5M. CEO Greenley sold C$5.8M in Jun 2025 (pre-ATH). Thornvale Holdings (director vehicle) sold USD $12M+ Dec 25-Jan 26. [FRESH]
Shares Outstanding 138,659,400 (per TipRanks as of Q1 2026 post-IPO) [FRESH]

POSITIONING READ Insider activity over the last 6 months is net heavy selling — not a single major buy close to current prices. The Thornvale Holdings dispositions (a director vehicle) and CEO Greenley’s June 2025 sale near C$29 show insiders were offloading well before the stock’s Q1 2026 run to C$67. That’s not a reason to avoid a momentum story but it removes the ‘management buying their own stock’ conviction signal. Short interest described as low means no squeeze potential from here — pullbacks have to find real buyers, not short covers.

5. TECHNICALS
Note: SMA levels estimated/derived from price context; ATH, 52w data scraped fresh. Direct Finviz/SMA scrape not completed due to access restrictions.

Indicator Tag Reading
SMA20 (TSX, CAD) [EST] Stock was above $50 CAD as recently as May 28; a 40% decline means price is well below any 20-day average
SMA50 (TSX, CAD) [EST] Likely around CAD $45-50 given the trajectory of the past 3 months of 50%+ gain and then sharp reversal
SMA200 (TSX, CAD) [EST] Likely in the CAD $30-35 range based on the 1-year chart from $20.85 low; still above
RSI (14) [PARTIAL] ChartMill showed RSI ~83 (~4 weeks ago) — overbought at that time. Post-ATH selloff has reset it lower; likely neutral-to-oversold now but not confirmed
ATR (14) [EST] Given 5.1% daily volatility (TradingView) and ~$40 CAD price, ATR roughly CAD $2.00-2.50 (~5-6% of price)
52-Week High (TSX) [FRESH] CAD $67.90 — set May 28, 2026
52-Week Low (TSX) [FRESH] CAD $20.85 — set roughly June 2025
Key Support (TSX) [EST] CAD $38-40 (current area, also prior consolidation); CAD $32-35 (Feb-March 2026 base before NYSE IPO); CAD $27-28 (longer-term demand zone)
Key Resistance (TSX) [EST] CAD $45-50 (breakdown zone, SMA cluster); CAD $55-58 (gap area from post-ATH collapse)
Open Gaps [EST] High likelihood of a gap down from ~$55 CAD area if stock re-tests — not confirmed without full chart
Chart Structure [PARTIAL] Post-ATH distribution / mean reversion. Stock ran from CAD $20.85 to $67.90 (+225%) in roughly 12 months. Now -40% from ATH in under 2 weeks. ATB downgrade + thin volume = no institutional support at these levels yet

TECHNICALS READ This is a broken momentum chart in early innings of a reset. A 225% 12-month run followed by a 40% peak-to-current decline in under 2 weeks is not orderly profit-taking — it’s a trend change. Bulls lose the thesis technically if CAD $38-40 fails to hold, with nothing confirmed until CAD $32-35. Bears need to be careful: low short interest means no forced covering if prices stabilize, and the SMA200 (estimated CAD $30-35) is a long way down. The best technical scenario for bulls is a 2-4 week base-building period at CAD $38-45 before trying the SMA50 again.

6. CATALYST MAP
Catalyst Date/Window Type Source Freshness
Q2 2026 Earnings Aug 5-7, 2026 Earnings TipRanks / StockAnalysis FRESH
CHORUS constellation launch Late 2026 (H2) Product/Revenue MDA IR newsroom (May 5, 2026) FRESH
CHORUS contract conversions (32 LOIs) Rolling H2 2026 Commercial catalyst MDA Press Release May 5, 2026 FRESH
BAE Systems / SSC EPOCH2 program execution Ongoing to 2027 Defense contract MDA Press Release Jun 2, 2026 FRESH
Airbus OneWeb antenna contract delivery Ongoing 2026-27 Satellite Systems revenue MDA Press Release Apr 20, 2026 FRESH
Canadarm3 / lunar robotics milestones Ongoing multiyear Gov’t/NASA robotics MEM (public record) MEM
SpaceX IPO / space sector re-rating 2026-2027 Macro/sector Multiple news sources PARTIAL
Globalstar acquisition resolution (Amazon/SpaceX rumors) Ongoing watch Contract risk Investing.com Mar 2026 FRESH
Analyst coverage expansion (NYSE listing) Ongoing Sentiment/valuation Jefferies, JPM, RBC, Stifel FRESH
NATO/Canadian defense budget cycle 2026-2027 Macro/defense Stockchase commentary PARTIAL
Fed rate path / USD-CAD FX June-Sept 2026 Macro Market data MEM

Macro overlay: Fed likely on hold through at least Q3 2026. USD/CAD at ~0.73 means USD-reporting investors get a headwind on TSX shares. VIX at 26.64 (per Yahoo) indicates elevated risk-off sentiment. Space sector is getting pre-IPO SpaceX fervor attention — a potential sector tailwind but also means MDA’s premium could compress if SpaceX directly competes on satellites.

CATALYST READ The catalyst stack is real and long-dated — Q2 earnings in August, CHORUS launch H2 2026, and ongoing contract wins. The problem is timing: the next hard catalyst (Q2 earnings) is 60 days away. That’s a lot of white space for a 40% pullback stock to drift lower. CHORUS is the wild card — 41 early commitments announced May 5 did not hold the stock, suggesting the market wants hard revenue, not LOIs. If CHORUS launches on schedule and books full contracts, that’s a multi-year revenue inflection. If it slips, the stock re-rates back toward the CAD $27-32 support zone.

7. FLOW & SENTIMENT
Signal Detail Tag
Options Flow MISSING — NYSE listing March 2026, options not confirmed active/liquid [MISSING]
Put/Call Ratio MISSING [MISSING]
Dark Pool Prints MISSING — no dark pool source scraped successfully [MISSING]
Retail Sentiment (Stockchase) 99+ analyst opinions, 4.15/5 avg rating. Tone: ‘likes it for defense theme, moat, $40B pipeline.’ Caveat: chart is rocky. Multiple experts flagging Globalstar/EchoStar risks but maintaining holds/buys. [FRESH]
Sentiment vs Price Diverging: analyst consensus still constructive (majority Buy ratings) but stock action is bearish. ATB downgrade May 29 was the sentiment inflection that confirmed the ATH. [FRESH]
Institutional Activity Connor, Clark & Lunn acquired a ‘significant stake’ recently (Gurufocus June 2026). This is a positive counterpoint to insider selling. [PARTIAL]
Insider Net Selling Signal Heavy — CAD $11.9M sold vs $100K bought in recent 90-day window. Director/CEO level sales. [FRESH]

FLOW READ With options data missing and dark pool not captured, flow conviction is low. What’s available is concerning: insiders net sold ~$12M in the past 90 days while the stock was appreciating, suggesting they knew something about the valuation ceiling. The retail/analyst community is still broadly bullish, which means this pullback has room to run until those Buy ratings start converting to Holds. The ATB downgrade (the first cracks) came with the stock at CAD $49-50; price is already much lower.

8. THESIS STRESS TEST

Bull Case Requires CHORUS constellation launches on schedule (late 2026) and 32 LOIs convert to multi-year contracts, unlocking a recurring data revenue stream that justifies the premium multiple
Q2 2026 earnings (Aug 5-7) show order bookings recovery — the CAD $143.9M Q1 bookings figure was a one-quarter anomaly, not a structural deceleration
Canadian and NATO defense budgets continue to increase, with MDA winning additional government prime contracts in space surveillance, EPOCH-class programs, and Canadarm3/lunar robotics
SpaceX IPO and general space sector re-rating lifts all boats — multiple expansion back toward 50x+ forward earnings
USD/CAD stabilizes or CAD strengthens, reducing the currency headwind for TSX-based investors

Bull Case Dies If Order bookings do not recover by Q2 — backlog at $3.7B is burning down and if bookings stay below $300M/quarter, the 2027 revenue story breaks
CHORUS launch slips beyond late 2026, pushing the recurring revenue inflection out 12-18 months and forcing a multiple de-rate
Globalstar is acquired by Amazon/SpaceX and the remaining ~$500M of that backlog is cancelled or renegotiated downward
BB- credit means any covenant pressure or need to refinance the $244.7M debt at higher rates compresses free cash flow

Bear Case Requires Continued multiple compression as the market re-rates growth stocks at 40x+ forward earnings; next support at CAD $32-35 (NYSE IPO base)
Q2 earnings disappoint on GAAP EPS or bookings — stock has no margin for error at current valuation

Bear Case Dies If A major contract win (new large constellation mandate, expanded Canadarm3 scope, or USAF prime award) refills the backlog in Q2 and confirms the CAD $40B pipeline is real
CHORUS achieves commercial launch and announces 3+ major government data subscriptions — proves the business model shift to recurring revenue

Base Case (30-90 Day)
MDA Space is a high-quality Canadian space company going through a necessary valuation reset after a speculative blow-off top. The operating fundamentals (32% revenue growth, net cash, 19-20% EBITDA margins) remain intact. But order bookings collapsed in Q1 and the stock was pricing a multiple that requires flawless execution with zero hiccups. The ATB downgrade from a local broker — who knows this story well — at the ATH is the key signal: the stock got ahead of itself. Most likely outcome over the next 30-90 days is continued base-building between CAD $35-50. Without a major contract announcement or CHORUS update, the stock drifts toward the CAD $35-38 zone, tests the pre-IPO base, and either finds institutional support there or requires Q2 earnings (August) to act as the next catalyst. A Globalstar negative update could push it through CAD $32.

9. RISK/REWARD POV

RISK/REWARD Buying a 40% pullback from ATH in a strong-growth industrial with net cash and a $40B pipeline sounds appealing — and it might be, but the entry matters. At CAD $40, you’re still paying 39-44x forward earnings for a BB- credit with collapsing order bookings. The reward scenario (CHORUS launch on schedule + bookings recovery in Q2) takes you back to CAD $55-65 over 6-12 months — roughly 40-60% upside. The risk scenario (CHORUS slips, bookings stay weak, multiple compresses to 25x) takes you to CAD $25-30 — roughly 25-35% further downside from here. That’s a 1.3-1.8x reward-to-risk, which is marginal at best unless you believe CHORUS is a certainty. The setup is NOT ready for a swing entry today — there is no technical base yet, thin volume confirms absence of institutional buying conviction, and the next hard catalyst is 60 days out. Wait for either a defined base (3-5 days of holding CAD $38-42 with volume returning) or a specific news catalyst.

10. ENTRY & EXIT PLAN
Sizing: Swing trade, 4-8 week horizon. Reduce size given MISSING options data, MISSING exact short interest, and thin TSX volume today.

Equity Plan (NYSE USD)
Element Level (USD) Logic
Entry Trigger (NYSE) $37.50-38.50 3-5 day base confirmation; volume returning to 1M+ per day on up-days; RSI bottoming above 35
Soft Stop $35.00 Below weekly support cluster; ~8% from entry
Hard Stop $32.00 Thesis invalidation — NYSE IPO floor; full valuation reset underway
Target 1 $43.00-44.00 Analyst consensus PT (JP Morgan OW); also SMA50 cluster
Target 2 $48-51 Jefferies $51 PT; prior base; 25-35% from entry
Time Horizon 4-8 weeks Before Q2 earnings Aug 5-7; exit or re-evaluate at that point
Sizing Note Half size or less No options data, missing short interest, no confirmed base — reduce exposure

Equity Plan (TSX CAD)
Element Level (CAD) Logic
Entry Trigger (TSX) CAD $38.00-42.00 Base confirmation after today’s -8.8% flush; watch for 2-3 day volume recovery
Soft Stop CAD $35.00 Intraday close below this level = exit
Hard Stop CAD $31.50 Pre-IPO demand zone; thesis broken below
Target 1 CAD $50.00 Gap fill zone / prior support before ATH run
Target 2 CAD $60-63 TSX analyst targets (CIBC C$57, RBC USD $58 implied ~CAD $79)
Time Horizon 4-10 weeks Pre-Q2 earnings re-evaluation

Options: Skip entirely — options data tagged [MISSING]. Sizing without IV data is guessing.

11. RISK REGISTER
Risk Severity Likelihood Trigger / Detail
Backlog/bookings deceleration HIGH HIGH Q1 bookings only $143.9M vs $803.9M YoY — if this is structural, revenue guidance breaks in 2027
CHORUS launch delay HIGH MEDIUM Any slip past H1 2027 pushes recurring revenue inflection and removes the premium multiple justification
Globalstar customer risk HIGH MEDIUM Amazon/SpaceX acquisition rumors; remaining ~$500M in backlog at risk if customer consolidates to internal supply
EchoStar contract loss (precedent) MEDIUM DONE Already occurred — $1.8B contract terminated. Management says pipeline rebuilt. History shows single-customer concentration risk is real.
Valuation / multiple compression HIGH HIGH At 39-44x forward earnings with BB- credit, any growth miss triggers a violent re-rate. Pattern already in motion.
FX headwind (CAD/USD) MEDIUM MEDIUM 31% of revenue is US-sourced but company reports in CAD. USD weakness vs CAD hurts US revenue translation.
CUSMA / US-Canada trade risk MEDIUM LOW-MED Analysts note 31% US revenue exposure. Policy uncertainty around CUSMA/trade deals could affect US government contract awards.
Dilution risk (shelf prospectus) LOW-MED LOW Base shelf filed March 2026 on SEDAR+ — optionality for future equity raises. Not imminent but the mechanism is in place.
Macro risk-off (VIX > 30) MEDIUM MEDIUM VIX at 26.64 on June 5 — already elevated. High-beta industrial tech names get sold hard in risk-off.
Thin NYSE float / liquidity MEDIUM ONGOING NYSE listing only March 2026. US institutional familiarity is low. Thin US market-hours liquidity amplifies volatility.
SatixFy integration risk MEDIUM MEDIUM Q3 2025 acquisition. Amortization already dragging GAAP EPS -11.5% YoY. Integration execution could strain margins if costs run high.

12. DATA GAPS SUMMARY
Data Gap Detail & Impact on Analysis
[1] Short Interest (exact %) Not scraped. Described qualitatively as ‘low’ in Finimize article. No hard number available from IIROC, TSX, or SEC short sale data.
[2] Borrow Fee Not scraped. Fintel requires login; no US short-sale data source returned a number.
[3] Exact Float Estimated from total shares (138.75M) minus insider ownership (~12.6%). Actual public float not confirmed from exchange data.
[4] Institutional Ownership % No 13F equivalent for TSX. SEDI insider data not scraped for full institutional breakdown. Qualitative only (CC&L recently added, institutional higher than OTC).
[5] Options Data No confirmed options activity — NYSE listing March 2026. Put/call ratio, IV rank, and OI walls all MISSING. Do not size options plays.
[6] Dark Pool Activity Not captured. No dark pool source returned MDA data.
[7] SMA20 / SMA50 / SMA200 (exact levels) Finviz not accessible; these levels estimated from price trajectory context. Mark as [EST] when trading against them.
[8] RSI (current) ChartMill showed RSI 83 ~4 weeks prior (overbought). Post-ATH selloff has since moved it lower but current RSI value not confirmed.
[9] ATR (exact) Estimated from TradingView’s stated 5.1% daily volatility. Not scraped directly.
[10] TTM Revenue discrepancy PitchBook shows $1.17B TTM as of Apr 2026; Yahoo Finance shows $2.1B TTM. Likely PitchBook is using a different period or older data. FY2025 actual = $1.63B per StockAnalysis. Used FY2025 figure as primary.
[11] SSR Active Status Not confirmed for NYSE or TSX today. Unknown whether SSR is active on either exchange.
[12] StockTwits / Reddit Direct Data No direct StockTwits scrape completed. Sentiment inferred from analyst commentary and Stockchase opinions.
[13] 2026 Full-Year Revenue Guidance (explicit) Company reaffirmed adj. EBITDA guidance ($320-370M) but explicit revenue guidance number was not scraped from press release text. Analyst estimates (~$1.83B) used as proxy.

Not financial advice. DYOR. Data sourced via live via 7 APIs June 9, 2026. All financial figures in CAD unless noted. MDA Space dual-listed TSX: MDA.TO / NYSE: MDA. Report generated via automated scrape-first methodology.